Write in a clean editor, then format for Cancer clinical trials in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Cancer clinical trials is a peer-reviewed journal published by Elsevier, covering Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Statistical Methods in Clinical Trials.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Cancer clinical trials 12 (2023) 45–58.
Formats any DOI in Cancer clinical trials style. No sign-up. |
| Publishes research in | Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations Statistical Methods in Clinical Trials Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers |
| ISSN | 0190-1206 |
| h-index | 5 |
| i10-index | 3 |
| Total citations | 122 |
| Top institutions publishing here | The University of Queensland |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Normal tissue toxicity of nitroaromatic radiosensitizers may originate in radiosensitizer/nitroreductase interaction. A study of two mammalian cell nitroreductases, xanthine oxidase and NADH cytochrome c reductase, shows that the efficiency of electron transfer is dependent on sensitizer electron affinity and not lipid solubility. Misonidazole and its demethylated metabolite (RO-05-9963), for example, are equally efficient as electron…
Leukemia is cancer of the blood and bone marrow, it is the most common cancer found in children and is found to be more than one fourth of pediatric cancers. It causes white blood cells to become abnormal and the body to become weak. This deficiency in the immune system reduces the body's ability to…
Purpose: Connective tissue growth factor (CTGF) is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and facilitates local desmoplasia, tumor progression and metastasis in animal models. This study evaluated safety and initial efficacy of the anti-CTGF antibody FG-3019 in combination with gemcitabine and erlotinib in patients with previously untreated Stage III or Stage IV PDAC. Methods: Eight escalating…
Background: Prophylactic nutritional support of head and neck cancer patients being treated with chemoradiation through placement of either a percutaneous endoscopic gastrostomy (PEG) tube or a nasogastric (NG) tube is well-established in clinical care. There is, however, little scientific evidence to support one over the other. Methods: We planned to conduct a randomized controlled trial to…
